Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in mice
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in mice ; volume:13 ; number:1 ; day:21 ; month:3 ; year:2023 ; pages:1-13 ; date:12.2023
Scientific reports ; 13, Heft 1 (21.3.2023), 1-13, 12.2023
- Creator
-
Horvath, Dennis
Temperton, Nigel
Mayora-Neto, Martin
Costa, Kelly Da
Cantoni, Diego
Horlacher, Reinhold
Günther, Armin
Brosig, Alexander
Morath, Jenny
Jakobs, Barbara
Groettrup, Marcus
Hoschuetzky, Heinz
Rohayem, Jacques
Meulen, Jan ter
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-31198-3
- URN
-
urn:nbn:de:101:1-2023080921215717392405
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Horvath, Dennis
- Temperton, Nigel
- Mayora-Neto, Martin
- Costa, Kelly Da
- Cantoni, Diego
- Horlacher, Reinhold
- Günther, Armin
- Brosig, Alexander
- Morath, Jenny
- Jakobs, Barbara
- Groettrup, Marcus
- Hoschuetzky, Heinz
- Rohayem, Jacques
- Meulen, Jan ter
- SpringerLink (Online service)
Other Objects (12)
Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in mice
A CpG-adjuvanted intranasal enterovirus 71 vaccine elicits mucosal and systemic immune responses and protects human SCARB2-transgenic mice against lethal challenge
Differential toll-like receptor 3 (TLR3) expression and apoptotic response to TLR3 agonist in human neuroblastoma cells
Immunogenicity of intraperitoneal and intranasal liposome adjuvanted VLP vaccines against SARS-CoV-2 infection
An intranasal cationic liposomal polysaccharide vaccine elicits humoral immune responses against Streptococcus pneumoniae
Intranasal immunization of mice with chimera of Salmonella Typhi protein elicits protective intestinal immunity
Distinctive expression of T cell guiding molecules in human autoimmune lymph node stromal cells upon TLR3 triggering
Nerve growth factor inhibits TLR3-induced inflammatory cascades in human corneal epithelial cells
17beta-estradiol suppresses TLR3-induced cytokine and chemokine production in endometrial epithelial cells
Poly I:C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway
Reovirus enhances cytotoxicity of natural killer cells against colorectal cancer via TLR3 pathway
Migration of murine intestinal dendritic cell subsets upon intrinsic and extrinsic TLR3 stimulation
Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in mice
A CpG-adjuvanted intranasal enterovirus 71 vaccine elicits mucosal and systemic immune responses and protects human SCARB2-transgenic mice against lethal challenge
Differential toll-like receptor 3 (TLR3) expression and apoptotic response to TLR3 agonist in human neuroblastoma cells
Immunogenicity of intraperitoneal and intranasal liposome adjuvanted VLP vaccines against SARS-CoV-2 infection
An intranasal cationic liposomal polysaccharide vaccine elicits humoral immune responses against Streptococcus pneumoniae
Intranasal immunization of mice with chimera of Salmonella Typhi protein elicits protective intestinal immunity
Distinctive expression of T cell guiding molecules in human autoimmune lymph node stromal cells upon TLR3 triggering
Nerve growth factor inhibits TLR3-induced inflammatory cascades in human corneal epithelial cells
17beta-estradiol suppresses TLR3-induced cytokine and chemokine production in endometrial epithelial cells
Poly I:C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway
Reovirus enhances cytotoxicity of natural killer cells against colorectal cancer via TLR3 pathway
Migration of murine intestinal dendritic cell subsets upon intrinsic and extrinsic TLR3 stimulation
Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in mice
A CpG-adjuvanted intranasal enterovirus 71 vaccine elicits mucosal and systemic immune responses and protects human SCARB2-transgenic mice against lethal challenge
Differential toll-like receptor 3 (TLR3) expression and apoptotic response to TLR3 agonist in human neuroblastoma cells
Immunogenicity of intraperitoneal and intranasal liposome adjuvanted VLP vaccines against SARS-CoV-2 infection
An intranasal cationic liposomal polysaccharide vaccine elicits humoral immune responses against Streptococcus pneumoniae
Intranasal immunization of mice with chimera of Salmonella Typhi protein elicits protective intestinal immunity
Distinctive expression of T cell guiding molecules in human autoimmune lymph node stromal cells upon TLR3 triggering
Nerve growth factor inhibits TLR3-induced inflammatory cascades in human corneal epithelial cells
17beta-estradiol suppresses TLR3-induced cytokine and chemokine production in endometrial epithelial cells
Poly I:C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway
Reovirus enhances cytotoxicity of natural killer cells against colorectal cancer via TLR3 pathway